CompletedNCT00745966
Quality of life with antipsychotics in bipolarity
About this title
Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder
Read the official source — NCT00745966Observational studyAges 18–65South Korea
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Kyunggi-do and 1 more locationSee all locations and recruitment
Study information
Study start dateJuly 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 1,000
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- South Korea
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00745966
- Official title
Show the full official title
A 8-Week, Multicenter, Open-Label, Observational Study of Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder
Get this study by email
Recruitment & locations
CompletedKyunggi-do · Daegu
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Who was this study for?
Listed age limits: 18 years to 65 years.
